2019 Speakers

 

Karen S Aboody, Professor, City of Hope Comprehensive Cancer Center

Nabil Al Humadi, Pharmacologist And Toxicologist, Food and Drug Administration (FDA)

Dr M Javad Aman, Chief Executive Officer, Integrated Biotherapeutics

Bruno Anspach, Director Of Clinical Operations Latin America - Vaccines, Glaxosmithkline

Eric Appel, Assistant Professor of Material Science and Engineering, Stanford University

Eric Appel | Assistant Professor of Material Science and Engineering | Stanford University » speaking at Vaccine West Coast

Sina Bavari, Chief Of Molecular And Translational Sciences, U.S. Army Medical Research Institute of Infectious Diseases

Sean Bennett, Senior Director Of Clinical Development and Medical Affairs, Emergent BioSolutions

Sean Bennett | Senior Director Of Clinical Development and Medical Affairs | Emergent BioSolutions » speaking at Vaccine West Coast

Praveen Bommareddy, Transnational Research Lead, Replimune

Praveen Bommareddy | Transnational Research Lead | Replimune » speaking at Vaccine West Coast

Maureen Bruhns, Senior Director, Analytical Development, Sutro Biopharma

David Canton, Director, R&D And Clinical Science, OncoSec Medical

Darrick Carter, Vice President - Adjuvant Technology, I.D.R.I.

Amit Chaudhuri, Vice President Of Research And Development, Medgenome Inc

Dr Chris Clegg, President, Founder and Chief Scientific Officer, TRIA Bioscience

Dr Chris Clegg | President, Founder and Chief Scientific Officer | TRIA Bioscience » speaking at Vaccine West Coast

Dr Rachel Clemens, Commercial Innovation Manager, Center for the Advancement of Science In Space

Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Jason E Comer, Assistant Professor, Department Microbiology And Immunology, University of Texas Medical Branch

Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics

Dr Rajeev Dadoo, Partner, S.R. One

Adil Daud, Professor of Hematology, Oncology and Director, U.C.S.F. Helen Diller Family Comprehensive Cancer Center

Mark M Davis, Professor, Microbiology & Immunology, Director, Stanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine

Tom Davis, Chief Marketing Officer, Genocea Biosciences

Dr Roland Dunbrack, Professor, Fox Chase Cancer Center

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK

Dr Jeffrey Froude, Major, Stm, Vaccines And Therapeutics Division, Defense Threat Reduction Agency

Dr Evanthia Galanis, Professor, Chair Molecular Medicine, Mayo Clinic

Dr Hanspeter Gerber, Senior Vice President and Chief Scientific Officer, 3T Biosciences

Aubree Gordon, Associate Professor Of Epidemiology, University of Michigan School of Public Health

Willem Hanekom, Deputy Director, Tb Vaccines,, Bill & Melinda Gates Foundation

Willem Hanekom | Deputy Director, Tb Vaccines, | Bill & Melinda Gates Foundation » speaking at Vaccine West Coast

Wouter Hazenbos, Scientist, Genentech

Charles Heffernan, Former Supply Chain Transformation And Technology Innovation Lead, Gsk And Member, BioPhorum Operations Group

Charles Heffernan | Former Supply Chain Transformation And Technology Innovation Lead, Gsk And Member | BioPhorum Operations Group » speaking at Vaccine West Coast

Priti Hegde, Director And Global Franchise Lead, Genentech

Dr Robert Hollingsworth, Vice President and Chief Scientific Officer, Cancer Vaccines and Immunotherapeutics, Pfizer

Dr Peter Hotez, Dean, National School Of Tropical Medicine, Director, Texas Children?S Hospital Center, Baylor College of Medicine

Beckie Ingram, Senior Lecturer/ Pi, QUB

Hasan Jafri, Senior Director, Clinical Research And Development, Infectious Disease And Vaccines, MedImmune Inc

Kathrin Jansen, Senior Vice President And Chief Scientific Officer, Pfizer

Kathrin Jansen | Senior Vice President And Chief Scientific Officer | Pfizer » speaking at Vaccine West Coast

Dr Joseph Jardine, Head Of Antibody Discovery, Institute For Protein Innovation

Vanessa Jonsson, Assistant Research Professor, City Of Hope National Medical Center

Vanessa Jonsson | Assistant Research Professor | City Of Hope National Medical Center » speaking at Vaccine West Coast

Dr Maria Karasarides, Executive Director, Immunooncology, Regeneron Pharmaceuticals

Dr Pravin Kaumaya, Professor, Ohio State University

Bruce Keyt, Chief Scientific Officer, IgM. Biosciences Inc

Lakshmi Khandke, Senior Program Advisor, PATH

Kevin Killeen, Chief Scientific Officer, Matrivax

Joseph Kim, Chief Executive Officer, Inovio Pharmaceuticals

Joseph Kim | Chief Executive Officer | Inovio Pharmaceuticals » speaking at Vaccine West Coast

Lacey Kitch, Director, Informatics, Parker Institute for Cancer Immunotherapy

Lacey Kitch | Director, Informatics | Parker Institute for Cancer Immunotherapy » speaking at Vaccine West Coast

Dr Chester Kitchen, Cancer Patient Advocate, Cancer Patient Advocate

Dr Chester Kitchen | Cancer Patient Advocate | Cancer Patient Advocate » speaking at Vaccine West Coast

Steven Kleiboeker, Vice-President, Research And Development, Viracor Eurofins

Dr Vadim Klyushnichenko, Vice President Of Pharmaceutical Development And Quality, Calibr, a division of Scripps Research

Alexander Koglin, Founder, NTxBio

Dr Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience

Theresa Lavallee, Head Of Translational Medicine, Parker Institute for Cancer Immunotherapy

Dr Andrew Lees, Scientific Director, Fina BioSolutions

Ofer Levy, Professor Of Pediatrics, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School

Kirsty Maclean, Associate Scientific Director, Biomarker And Translational Strategy, Definiens

Dr Sumithra Mandrekar, Professor Of Biostatistics And Oncology, Mayo Clinic

Wouter Meuleman, Director, Venture Investments, Illumina Ventures

Michael Mitchell, Professor, University of Pennsylvania

Michael Mitchell | Professor | University of Pennsylvania » speaking at Vaccine West Coast

Dr Martin Moore, Chief Executive Officer, Meissa Vaccines, Inc

Justin Moran, Senior Bioprocess Development Director, Pfizer

Bibhash Mukhopadhyay, Principal, New Enterprise Associates

Bibhash Mukhopadhyay | Principal | New Enterprise Associates » speaking at Vaccine West Coast

Michael Murray, Analyst, Biotechnology Value Fund

Duncan Mwangi, Research Director, Zoetis

Stephen Nagler, Executive Director, MedPro Investors Llc

Andreas Niethammer, Senior Vice President, Head of Clin Development, Immunotherapy Solid Tumors, Sorrento Therapeutics Inc

Andreas Niethammer | Senior Vice President, Head of Clin Development, Immunotherapy Solid Tumors | Sorrento Therapeutics Inc » speaking at Vaccine West Coast

Dr Susan Old, Deputy Director Of The Division Of Extramural Activities, NIAID

Dr Susan Old | Deputy Director Of The Division Of Extramural Activities | NIAID » speaking at Vaccine West Coast

Tim Phares, Head of Immunology, Explorations in Global Health (ExGloH), Leidos

Tim Phares | Head of Immunology, Explorations in Global Health (ExGloH) | Leidos » speaking at Vaccine West Coast

Dr Grant Pickering, Chief Executive Officer, SutroVax, Inc

Clemencia Pinilla, Associate Member, Torrey Pines Institute for Molecular Studies

Jan Poolman, Head Bacterial Vaccine Discovery And Early Development, Janssen

Mary Jo Potter, Founder And Chief Executive Officer, Healthcare Angels

Bali Pulendran, Department Of Pathology, Microbiology&Immunology, Stanford University School of Medicine

Dr Steven Reed, Founder, Distinguished Scientist, Infectious Disease Research Institute

Tony Reid, Chief Scientific Officer, EpicentRx

John Ross, Vice President, Protein Therapeutics, Cue Biopharma

John Ross | Vice President, Protein Therapeutics | Cue Biopharma » speaking at Vaccine West Coast

Dr Raphael Rousseau, Executive Vice President And Head Of Product Development And Chief Medical Officer, Gritstone Oncology

Sarah Royalty Tredo, Director, Emergent Biosolutions

Naik Rumi Armaghan, Director And Head, Sanofi Pasteur

Helen Sabzevari, President, Precigen

Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Bita Sahaf, Technical Director, Stanford CCSU; Correlatives for Parker Institute for Cancer Immunotherapy; Snr Research Scientist, Stanford Cancer Institute

Bita Sahaf | Technical Director, Stanford CCSU; Correlatives for Parker Institute for Cancer Immunotherapy; Snr Research Scientist | Stanford Cancer Institute » speaking at Vaccine West Coast

Richard Scheuermann, Director, J Craig Venter Institute

Dr Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology

Dr Mike Schopperle, Chief Executive Officer, CureMeta Llc

Martina Sersch, Chief Medical Officer, Mustang Bio

Dr Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Infectious Disease Institute

William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC

Julia Spencer, Associate Vice President, Global Vaccine Public Policy, Partnerships, Merck

Dr Gary Starling, Associate Vice President, Discovery Biologics, Merck

Angelos Stergiou, President & Chief Executive Officer, Sellas Life Sciences Group

Dr Lesley Stolz, Head Of Jlabs Bay Area, Annexon Biosciences

Nancy Sullivan, Chief And Biodefense Research Section, Vaccine Research Center, National Institutes of Health

Jun Tang, Senior Manager Philanthropic Venture Fund And Clinical Accelerator, Cancer Research Institute

Dr Raymond Tesi, Chief Executive Officer, INmune Bio

Dr Sangeeta Tiwari, Associate (Faculty), Albert Einstein College of Medicine

Dr Steven Townson, Senior Principal Scientist, Early Oncology Development, Merck Research Laboratories

Ovid Trifan, Chief Medical Officer, Senior Vice President Of Clinical Development, Apexigen, Inc

Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals

Chia-Wei Tsai, Branch Chief, BARDA

Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart

Louis-Philippe Vezina, Chief Executive Officer, Angany

Kalpit Vora, Director, Merck And Company

Dr I Ming Wang, Director, Pfizer

Jo Anne Welsch, Scientific Director, Path

Jo Anne Welsch | Scientific Director | Path » speaking at Vaccine West Coast

Nancy Whiting, Sr Vice President, Development, Seattle Genetics Inc

Jon Wigginton, Chief Medical Officer And Senior Vice President Of Clinical Development, MacroGenics

Jon Wigginton | Chief Medical Officer And Senior Vice President Of Clinical Development | MacroGenics » speaking at Vaccine West Coast

Prof Ignasio Wistuba, Professor And Chairman, The University of Texas MD Anderson Cancer Center

Larry Zeitlin, President, Mapp Biopharmaceutical, Inc.

 

DOWNLOAD PROSPECTUS

 

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156

oliver.breed@terrapinn.com


To speak:
Lauren Sheppard
+44 (0)207 092 1211

lauren.sheppard@terrapinn.com